TSB and TcB Bilirubin Measurement Methods Explained

Introduction to Bilirubin Measurement in Neonates

Accurate measurement of bilirubin levels is the cornerstone of neonatal jaundice management. The decision to initiate phototherapy, escalate to intensive phototherapy, or proceed with exchange transfusion depends entirely on reliable bilirubin values interpreted in the context of the infant's age, gestational age, and risk factors. Two primary methods are used in clinical practice: Total Serum Bilirubin (TSB) measured through a laboratory blood test, and Transcutaneous Bilirubin (TcB) measured non-invasively using a bilirubinometer device.

In India, where neonatal jaundice is ubiquitous and healthcare resources vary widely, the choice and availability of bilirubin measurement methods significantly influence clinical practice. This guide provides a thorough technical comparison of TSB and TcB methods, examines their clinical applications and limitations, and explores the availability of these testing modalities in Kolkata's healthcare system.

Total Serum Bilirubin (TSB): The Gold Standard

TSB measurement involves collecting a blood sample, usually via heel prick capillary sample or venepuncture, and analysing it in a laboratory to quantify the concentration of bilirubin in the serum.

Laboratory Methods

Several laboratory techniques are used to measure TSB. The diazo method (Jendrassik-Grof) is the most commonly used technique. It involves reacting bilirubin with diazotized sulfanilic acid. The direct (conjugated) fraction reacts without an accelerant, while the total bilirubin requires an accelerant such as caffeine to solubilize the unconjugated fraction. The difference gives the indirect (unconjugated) bilirubin. This method is available on most automated chemistry analyzers in hospital laboratories.

Direct spectrophotometry involves measuring the absorbance of undiluted serum at specific wavelengths. This method is used in point-of-care bilirubinometers such as the Reichert Unistat and similar devices. It provides total bilirubin only, not fractionated values, but is faster than the diazo method.

High-performance liquid chromatography (HPLC) is the reference method providing the most accurate bilirubin quantification including all isomers. It is used primarily in research settings due to cost and complexity.

Advantages of TSB

• Gold standard measurement with established clinical thresholds based on TSB values
• Provides fractionated bilirubin (direct and indirect) when needed for diagnostic evaluation
• Reliable at all bilirubin levels including the high range relevant to exchange transfusion decisions
• Not affected by skin colour, phototherapy, or skin maturity
• Results can be trended accurately over time for monitoring treatment response

Limitations of TSB

• Requires blood draw: painful for the infant and distressing for parents
• Turnaround time: laboratory processing takes 30 minutes to 2 hours depending on the facility
• Sample volume: requires 0.3 to 1.0 ml of blood, which is significant for a preterm infant
• Pre-analytical variables: hemolysis of the sample can falsely lower results; exposure to light can degrade bilirubin in the sample tube
• Requires lab resources: reagent and processing needs accumulate with frequent monitoring
• Availability: some rural health centres may lack laboratory capability for reliable bilirubin analysis

Transcutaneous Bilirubin (TcB): Non-Invasive Screening

TcB measurement uses a handheld device pressed against the infant's skin, typically on the forehead or sternum, to estimate bilirubin concentration based on the optical properties of the skin.

How TcB Devices Work

Transcutaneous bilirubinometers emit light of multiple wavelengths into the skin and measure the reflected light. Bilirubin deposited in the subcutaneous tissue absorbs specific wavelengths, and the device's internal algorithm calculates an estimated bilirubin value based on the spectral analysis of reflected light. Advanced devices like the Drager JM-105 use multi-wavelength analysis to correct for confounders such as melanin, haemoglobin, and skin maturity.

The measurement is instantaneous (taking 1 to 3 seconds per reading), painless, and requires no consumables. A single device can be used for thousands of measurements with periodic calibration checks.

Advantages of TcB

• Non-invasive: no blood draw, no pain, no risk of infection at puncture sites
• Instant results: no laboratory turnaround time, enabling immediate clinical decisions for screening
• No per-test consumables: the device investment is amortized over thousands of measurements
• Suitable for universal screening: can be used to screen every newborn before discharge
• Reduces the number of blood draws: used as a first-line screen with TSB only when TcB exceeds a threshold
• Portable: can be used at the bedside, in outpatient clinics, and during home visits

Limitations of TcB

• Less accurate at high bilirubin levels: TcB tends to underestimate TSB above 15 mg per dL in many studies
• Affected by skin colour: accuracy may vary in very dark-skinned or very fair-skinned infants, though modern devices have improved algorithms for this
• Unreliable during phototherapy: phototherapy bleaches bilirubin in the skin, causing TcB to underestimate serum levels. TcB should not be used to monitor response to phototherapy
• Less validated in preterm infants below 35 weeks: skin immaturity and oedema affect readings
• Device calibration: requires periodic calibration checks and may drift between servicing
• Not a substitute for TSB for treatment decisions: TcB is a screening tool, not a confirmatory test

Clinical Comparison: TSB vs TcB

Parameter	TSB	TcB
Method	Blood sample, lab analysis	Skin reflectance, device algorithm
Invasiveness	Invasive (heel prick or venepuncture)	Non-invasive
Time to Result	30 min to 2 hours	Instant (1-3 seconds)
Accuracy at Low TSB (<12)	High	Good (within ± 1.5 mg/dL)
Accuracy at High TSB (>15)	High	Variable, may underestimate
During Phototherapy	Reliable	Unreliable
Skin Colour Effect	None	Possible bias in extreme pigmentation
Preterm (<35 weeks)	Reliable	Less validated
Per-Test Consumables	Reagents required	None after device acquisition
Fractionation	Yes (direct/indirect)	No (total estimate only)
Universal Screening	Less practical due to invasiveness	Ideal

Clinical Workflow: Integrating TSB and TcB

The optimal approach in Indian NICUs and postnatal wards integrates both methods in a stepwise protocol.

1. Universal TcB Screening: Measure TcB on every newborn at 24 hours of age or before discharge, whichever is earlier. Plot the TcB value on an hour-specific nomogram (Bhutani nomogram or an Indian-validated equivalent).
2. Risk Stratification: If TcB falls in the low-risk zone, no further testing is needed before discharge with standard follow-up. If TcB is in the intermediate or high-risk zone, obtain a confirmatory TSB.
3. Treatment Decision: Treatment decisions (phototherapy initiation, exchange transfusion) should always be based on TSB values, not TcB alone. The AAP phototherapy and exchange transfusion thresholds are defined for TSB.
4. Monitoring During Phototherapy: Once phototherapy is initiated, monitor response using TSB at 4 to 6 hours after starting treatment and then every 8 to 12 hours. Do not use TcB during active phototherapy.
5. Post-Phototherapy: TcB can be used again 24 hours after discontinuation of phototherapy to screen for rebound jaundice, with TSB confirmation if TcB is elevated.

Bilirubin Testing in Kolkata Hospitals

Kolkata, with its rich medical heritage and diverse hospital network, provides a comprehensive but variable landscape for bilirubin testing services.

Government Hospitals

• SSKM Hospital (PG Hospital): The largest government hospital in Kolkata with a busy neonatal unit. TSB is routinely available through the central laboratory. TcB devices have been introduced in the postnatal wards for screening.
• NRS Medical College: High-volume maternity and neonatal services. TSB testing is available but turnaround times can be prolonged during peak hours due to laboratory load.
• Calcutta Medical College: One of the oldest medical institutions in Asia. The neonatal unit uses TSB for jaundice management with laboratory services available round the clock.
• BC Roy Children's Hospital: Dedicated paediatric hospital with a large NICU. Uses both TSB and TcB for jaundice assessment in high-volume settings.

Private Hospitals

• AMRI Hospital: Multiple locations in Kolkata (Dhakuria, Salt Lake, Mukundapur) with Level III NICUs. TcB screening is standard practice with rapid TSB availability.
• Fortis Hospital, Anandapur: Modern NICU with both TcB devices and point-of-care bilirubinometers for rapid TSB estimation.
• Apollo Gleneagles Hospital: Comprehensive neonatal services with integrated TcB screening and laboratory TSB protocols.
• Peerless Hospital and Medica Superspecialty Hospital: Growing neonatal departments with modern diagnostic capabilities.
• Cloudnine Hospital, Kolkata: Mother-and-child centre with TcB screening as part of the universal newborn assessment.

Bilirubin Testing Availability in Kolkata

Testing Method	Government Hospital	Private Hospital	Private Lab (SRL, Metropolis)
TSB	Available	Available with rapid turnaround	Available with home collection
TcB	Increasingly available	Standard practice at major centres	Not typically available

Emerging Technologies and Indian Innovation

The bilirubin measurement landscape is evolving with new technologies that could further improve accessibility and accuracy in Indian settings.

• Smartphone-Based Bilirubin Estimation: Research groups at IIT and AIIMS have developed smartphone applications that estimate bilirubin levels from photographs of the infant's skin. While not yet clinically validated to replace TSB or TcB, these tools show promise for community-level screening in areas without device or laboratory access.
• Point-of-Care Microfluidic Devices: Miniaturized devices requiring minimal blood volume of 50 to 100 microlitres that can provide TSB results within minutes at the bedside. These are beginning to enter the Indian market and could bridge the gap between the convenience of TcB and the accuracy of TSB.
• Indian-Manufactured TcB Devices: Companies like Phoenix Medical Systems in Chennai and Medi Waves are developing transcutaneous bilirubinometers designed for the Indian market, making this technology more accessible across diverse healthcare settings.

Comprehensive Jaundice Management: HEAMAC supports neonatal jaundice management in Kolkata and across India by providing rental phototherapy equipment that complements accurate bilirubin monitoring. When TcB screening identifies neonates requiring treatment, rapid access to high-quality LED phototherapy through HEAMAC's rental network ensures timely initiation of therapy, whether in hospital or at home for eligible patients.

Recommendations for Indian NICUs

• Implement universal pre-discharge TcB screening using a validated device with appropriate nomograms.
• Establish clear institutional thresholds for when TcB readings trigger confirmatory TSB testing.
• Never use TcB to monitor phototherapy response or make exchange transfusion decisions.
• Ensure TSB laboratory services are available 24/7 with turnaround times under 60 minutes for NICU samples.
• Train nursing staff in proper TcB measurement technique: consistent site (sternum preferred), adequate pressure, and multiple readings averaged.
• Calibrate TcB devices per manufacturer recommendations and maintain calibration logs.
• Use hour-specific bilirubin nomograms for risk stratification, not single threshold values.

Conclusion

TSB and TcB are complementary tools in the management of neonatal jaundice. TSB remains the gold standard for treatment decisions while TcB provides an invaluable non-invasive screening tool that reduces unnecessary blood draws and enables universal screening. Indian NICUs, including those in Kolkata, benefit from integrating both methods into a structured clinical workflow. As technology advances and more devices become available through Indian manufacturers, the goal of accurate, accessible bilirubin measurement for every Indian newborn moves closer to reality.